+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Folate Receptor alpha (FRa) Targeted Therapy Pipeline Review - Product Thumbnail Image

Folate Receptor alpha (FRa) Targeted Therapy Pipeline Review

  • Report
  • June 2025
  • Global
From
CD40 Agonists & CD40/L Antagonists Pipeline Review - Product Thumbnail Image

CD40 Agonists & CD40/L Antagonists Pipeline Review

  • Report
  • June 2025
  • Global
From
Denosumab (Prolia & Xgeva) Biosimilars Pipeline Review - Product Thumbnail Image

Denosumab (Prolia & Xgeva) Biosimilars Pipeline Review

  • Report
  • June 2025
  • Global
From
Aflibercept (Eylea) Biosimilars Pipeline Review - Product Thumbnail Image

Aflibercept (Eylea) Biosimilars Pipeline Review

  • Report
  • June 2025
  • Global
From
Claudin 18.2-Targeted Immunotherapy: A Landscape Analysis of Stakeholders, Drug Modalities, Pipeline and Business Opportunities from An Industry Perspective - Product Thumbnail Image

Claudin 18.2-Targeted Immunotherapy: A Landscape Analysis of Stakeholders, Drug Modalities, Pipeline and Business Opportunities from An Industry Perspective

  • Report
  • August 2023
  • 267 Pages
  • Global
From
GPRC5D-Targeted Therapy: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis - Product Thumbnail Image

GPRC5D-Targeted Therapy: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis

  • Report
  • July 2022
  • 60 Pages
  • Global
From
ROR1-Targeted Therapy: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis - Product Thumbnail Image

ROR1-Targeted Therapy: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis

  • Report
  • June 2022
  • 115 Pages
  • Global
From
Cadherin 17: A Target Opportunity To Develop Effector-Enhanced Drug Modalities - Product Thumbnail Image

Cadherin 17: A Target Opportunity To Develop Effector-Enhanced Drug Modalities

  • Report
  • May 2022
  • 32 Pages
  • Global
From
Claudin 6: A Target Opportunity To Develop Effector-Enhanced Drug Modalities - Product Thumbnail Image

Claudin 6: A Target Opportunity To Develop Effector-Enhanced Drug Modalities

  • Report
  • May 2022
  • 50 Pages
  • Global
From
Precision Cancer Therapeutics, 2022 - Product Thumbnail Image

Precision Cancer Therapeutics, 2022

  • Report
  • November 2022
  • 154 Pages
  • Global
From
CAR-T Cell Therapy Market Review - Product Thumbnail Image

CAR-T Cell Therapy Market Review

  • Report
  • December 2019
  • 59 Pages
  • Global
From
Antibody Drug Conjugates (ADC) Market by Product (Kadcyla, Enhertu, Padcev, Polivy), Linker Type (Cleavable, Non-Cleavable), Payload Type (Calicheamicin, MMAE), Target (HER2, CD30, CD22), Disease, and Region - Forecast to 2028 - Product Thumbnail Image

Antibody Drug Conjugates (ADC) Market by Product (Kadcyla, Enhertu, Padcev, Polivy), Linker Type (Cleavable, Non-Cleavable), Payload Type (Calicheamicin, MMAE), Target (HER2, CD30, CD22), Disease, and Region - Forecast to 2028

  • Report
  • October 2023
  • 273 Pages
  • Global
From
Prostate Health Market by Disease Indication (Prostate Cancer, PARP Inhibitors, Cytotoxic Drug, Benign Prostate Hyperplasia (BPH), Tamsulosin, 5 Alpha Reductase, Prostatitis, OTC, Prescription (Rx), & Region (NA, Europe, APAC) - Global Forecasts to 2026 - Product Thumbnail Image

Prostate Health Market by Disease Indication (Prostate Cancer, PARP Inhibitors, Cytotoxic Drug, Benign Prostate Hyperplasia (BPH), Tamsulosin, 5 Alpha Reductase, Prostatitis, OTC, Prescription (Rx), & Region (NA, Europe, APAC) - Global Forecasts to 2026

  • Report
  • December 2021
  • 95 Pages
  • Global
From
Leukemia Therapeutics Market by Type (CLL, ALL, CML, AML), Treatment Type (Chemotherapy & Targeted Drugs), Mode of Administration (Oral, Injectable), Molecule Type (Small Molecules, Biologics), Gender, and Region - Global Forecast to 2024 - Product Thumbnail Image

Leukemia Therapeutics Market by Type (CLL, ALL, CML, AML), Treatment Type (Chemotherapy & Targeted Drugs), Mode of Administration (Oral, Injectable), Molecule Type (Small Molecules, Biologics), Gender, and Region - Global Forecast to 2024

  • Report
  • May 2019
  • 126 Pages
  • Global
From
Global CDK 4/6 Inhibitor Drugs Market Outlook 2023-2035 - Product Thumbnail Image

Global CDK 4/6 Inhibitor Drugs Market Outlook 2023-2035

  • Report
  • January 2024
  • 157 Pages
  • Global
From
Global Oncolytic Virus Therapy Market Outlook to 2035 - Product Thumbnail Image

Global Oncolytic Virus Therapy Market Outlook to 2035

  • Report
  • April 2023
  • 144 Pages
  • Global
From
Global Claudin 18.2 Targeted Therapy Market Opportunity & Clinical Trials Insight 2028 - Product Thumbnail Image

Global Claudin 18.2 Targeted Therapy Market Opportunity & Clinical Trials Insight 2028

  • Report
  • December 2023
  • 220 Pages
  • Global
From
US Cancer Biosimilar Market Opportunity, Drug Dosage, Price & Clinical Trials Insight 2026 - Product Thumbnail Image

US Cancer Biosimilar Market Opportunity, Drug Dosage, Price & Clinical Trials Insight 2026

  • Report
  • March 2021
  • 240 Pages
  • United States
From
Artificial Intelligence (AI) in Oncology Market Report 2023-2033 - Product Thumbnail Image

Artificial Intelligence (AI) in Oncology Market Report 2023-2033

  • Report
  • June 2023
  • 289 Pages
  • Global
From
Brazil Cancer Drugs Clinical Trials Insight 2024 - Product Thumbnail Image

Brazil Cancer Drugs Clinical Trials Insight 2024

  • Report
  • August 2024
  • 660 Pages
  • Brazil
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more